Noncolorectal

News

Comprehensive Molecular Panel Testing in GI Cancers

09/26/2020

At the Great Debates & Updates in GI Malignancies, Scott Kopetz, MD, PhD, participated in a lively debate on comprehensive molecular panel testing for GI Cancers, and spoke in favor of it.

At the Great Debates & Updates...

09/26/2020

Oncology

Videos

Current and Emerging Therapy Options in Pancreatic Cancer

09/26/2020

Jordan Berlin, MD, shares an overview of new treatment options and trials in pancreatic cancer at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.

Jordan Berlin, MD, shares an...

09/26/2020

Oncology

Videos

Yelena Janjigian, MD, Discusses HER2-Targeting Updates for Metastatic/Locally Advanced Esophageal, Gastric Cancers

07/28/2020

Dr Janjigian shares her perspective on HER2-targeted therapy data from the DELIVER, KEYNOTE-061, DESTINY-Gastric01, and RTOG1010 trials.

Dr Janjigian shares her...

07/28/2020

Oncology

Conference Insider

Ripretinib Yields Clinically Meaningful Benefit in Advanced GIST

07/07/2020

Patients given ripretinib for advanced GIST in the INVICTUS trial had improved PFS and OS, according to data presented at the virtual ESMO World Congress on GI Cancer.

Patients given ripretinib for...

07/07/2020

Oncology

Videos

Deborah Mukherji, MD, Talks Gaps in Research and Potential for Further Study on HCC, Biliary Tract Cancers

07/04/2020

Dr Mukherji summarizes 3 posters that were presented at the virtual ESMO World Congress on GI Cancer, which identify gaps in research and can inform future biliary tract cancer trials.

Dr Mukherji summarizes 3 posters...

07/04/2020

Oncology

Podcasts

First-Line NALIRIFOX Shows Promising Antitumor Activity in Locally Advanced/Metastatic PDAC

07/02/2020

Zev Wainberg, MD, discusses emerging data from the phase 1/2 trial of first-line liposomal irinotecan plus 5-fluorouracil/leucovorin plus oxaliplatin for PDAC.

Zev Wainberg, MD, discusses...

07/02/2020

Oncology

Videos

Anant Ramaswamy, MD, on the Efficacy of Capecitabine-Irinotecan vs Irinotecan for Advanced Gallbladder Cancer

07/01/2020

Dr Ramaswamy provides perspective on a phase 2 trial comparing the efficacy of irinotecan administered with or without capecitabine for advanced gallbladder cancer.

Dr Ramaswamy provides...

07/01/2020

Oncology

Conference Insider

07/01/2020

The safety of maintenance olaparib for gBRCA-mutated metastatic pancreatic cancer is consistent regardless of patient age, according to data presented at the ESMO World Congress on GI Cancer.

The safety of maintenance...

07/01/2020

Oncology

News

Infigratinib Yields PFS, ORR Benefit in Patients With Cholangiocarcinoma and FGFR2 Fusions

07/01/2020

In a phase 2 trial, third- and later-line treatment with infigratinib led to a meaningful benefit in survival and response among patients with cholangiocarcinoma and FGFR2 fusions.

In a phase 2 trial, third- and...

07/01/2020

Oncology

Conference Insider

Experts Develop Nomogram That Predicts Survival in Patients With Unresectable Pancreatic Cancer

07/01/2020

Findings from a study presented at the ESMO World Congress on GI Cancer posit that a nomogram can conveniently predict survival in patients with unresectable pancreatic cancer.

Findings from a study presented...

07/01/2020

Oncology